19 machine-learning-phd positions at University of California, San Francisco in america
-
covered by a bargaining unit agreement, there will be specific rules about where a new hire would be placed on the range. To learn more about the benefits of working at UCSF, including total compensation
-
at UCSF in a similar role. For roles covered by a bargaining unit agreement, there will be specific rules about where a new hire would be placed on the range. To learn more about the benefits of working
-
discipline, with strong training and experience in Computational Biology, Statistics, Machine Learning, Data Science, or Data Engineering. Demonstrated track record of analyzing large biological datasets
-
bargaining unit agreement, there will be specific rules about where a new hire would be placed on the range. To learn more about the benefits of working at UCSF, including total compensation, please visit
-
Division. Under the supervision of the two Principal Investigators, Ari Green, MD, and Trent Watkins, PhD, the SRA III will be responsible for facilitating the research of the two laboratories through lab
-
hire would be placed on the range. To learn more about the benefits of working at UCSF, including total compensation, please visit: https://ucnet.universityofcalifornia.edu/compensation-and-benefits
-
be placed on the range. To learn more about the benefits of working at UCSF, including total compensation, please visit: https://ucnet.universityofcalifornia.edu/compensation-and-benefits/index.html
-
. To learn more about the benefits of working at UCSF, including total compensation, please visit: https://ucnet.universityofcalifornia.edu/compensation-and-benefits/index.html Department Description The UCSF
-
University of California, San Francisco | San Francisco, California | United States | about 2 months ago
be specific rules about where a new hire would be placed on the range. To learn more about the benefits of working at UCSF, including total compensation, please visit: https
-
with stable function of liver or kidney allografts on chronic immunosuppression (PARADIGM). The PARADIGM trial is under the direction of the principal investigator (PI) Peter Stock, MD, PhD. The primary